Monday, December 23, 2024
HomeTagsATAK Receptors

ATAK Receptors

Myeloid Therapeutics Presents Late-Breaking Data at AACR 2022 Demonstrating the Ability of its ATAK Receptors

Myeloid Therapeutics, Inc., a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases, presented new late-breaking data at the American Association...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics